Homology Medicines, Inc. (FIXX) financial statements (2021 and earlier)

Company profile

Business Address ONE PATRIOTS PARK
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments217262215
Cash and cash equivalents2175438
Short-term investments 209177
Other undisclosed current assets247
Total current assets:220267222
Noncurrent Assets
Operating lease, right-of-use asset6 
Property, plant and equipment374336
Other undisclosed noncurrent assets112
Total noncurrent assets:444437
TOTAL ASSETS:264311259
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12820
Accounts payable5316
Accrued liabilities010
Employee-related liabilities753
Deferred revenue61
Deferred rent credit 11
Other undisclosed current liabilities525
Total current liabilities:231225
Noncurrent Liabilities
Long-term debt and lease obligation13  
Operating lease, liability13 
Liabilities, other than long-term debt32409
Deferred revenue3230
Deferred rent credit 109
Other undisclosed noncurrent liabilities  29
Total noncurrent liabilities:454039
Total liabilities:685264
Stockholders' equity
Stockholders' equity attributable to parent196259195
Common stock000
Additional paid in capital524458292
Accumulated other comprehensive income (loss) 0(0)
Accumulated deficit(328)(200)(97)
Total stockholders' equity:196259195
TOTAL LIABILITIES AND EQUITY:264311259

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Sublease income1 
Gross profit:324
Operating expenses(133)(112)(65)
Operating loss:(130)(110)(62)
Nonoperating income364
Investment income, nonoperating2  
Other nonoperating income264
Loss before gain (loss) on sale of properties:(127)(104)(57)
Other undisclosed net loss(2)  
Net loss available to common stockholders, diluted:(129)(104)(57)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(129)(104)(57)
Comprehensive loss:(129)(104)(57)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)
Comprehensive loss, net of tax, attributable to parent:(129)(104)(57)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: